Collplant Biotechnologies logo

Collplant Biotechnologies Share Price Today

(NASDAQ: CLGN)

Collplant Biotechnologies share price is $2.42 & ₹206.83 as on 18 Apr 2025, 2.30 'hrs' IST

$2.42

Market is closed - opens 7 PM, 21 Apr 2025

View live Collplant Biotechnologies share price in Dollar and Rupees. Guide to invest in Collplant Biotechnologies stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Collplant Biotechnologies, along with analyst recommendations, forecasts, and comprehensive financials.

Collplant Biotechnologies share price movements

  • Today's Low: $2.42
    Today's High: $2.46

    Day's Volatility :1.63%

  • 52 Weeks Low: $2.20
    52 Weeks High: $6.75

    52 Weeks Volatility :67.41%

Collplant Biotechnologies (CLGN) Returns

PeriodCollplant Biotechnologies LtdIndex (Russel 2000)
3 Months
-39.5%
0.0%
6 Months
-38.27%
0.0%
1 Year
-53.46%
0.0%
3 Years
-74.5%
-12.9%

Collplant Biotechnologies (CLGN) Key Statistics

in dollars & INR

Previous Close
$2.42
Open
$2.46
Today's High
$2.46
Today's Low
$2.42
Market Capitalization
$27.7M
Today's Volume
$2.8K
52 Week High
$6.75
52 Week Low
$2.2
Revenue TTM
$515.0K
EBITDA
$-16.2M
Earnings Per Share (EPS)
$-1.45
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-79.46%

How to invest in Collplant Biotechnologies Stock (CLGN) from India?

It is very easy for Indian residents to invest directly in Collplant Biotechnologies from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Collplant Biotechnologies stock in both Indian Rupees (INR) and US Dollars (USD). Search for Collplant Biotechnologies or CLGN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Collplant Biotechnologies or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Collplant Biotechnologies shares which would translate to 0.353 fractional shares of Collplant Biotechnologies as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Collplant Biotechnologies, in just a few clicks!

Returns in Collplant Biotechnologies (CLGN) for Indian investors in Rupees

The Collplant Biotechnologies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Collplant Biotechnologies investment value today

Current value as on today

₹48,879

Returns

₹51,121

(-51.12%)

Returns from Collplant Biotechnologies Stock

₹53,462 (-53.46%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Collplant Biotechnologies (CLGN)

200%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Collplant Biotechnologies Stock from India on INDmoney has increased by 200% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Collplant Biotechnologies

  • Parallel Advisors, LLC

    0.03%

Analyst Recommendation on Collplant Biotechnologies

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Collplant Biotechnologies(by analysts ranked 0 to 5 stars)

Analyst Forecast on Collplant Biotechnologies Stock (CLGN)

What analysts predicted

Upside of 478.51%

Target:

$14.00

Current:

$2.42

Insights on Collplant Biotechnologies Stock (Ticker Symbol: CLGN)

  • Price Movement

    In the last 3 months, CLGN stock has moved down by -40.0%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 4.0K → 164.0K (in $), with an average increase of 97.6% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -4.32M → -3.87M (in $), with an average increase of 11.6% per quarter
  • CLGN vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 129.6%
  • CLGN vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 103.0%
  • Price to Sales

    ForCLGN every $1 of sales, investors are willing to pay $53.8, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.

Collplant Biotechnologies Technicals Summary

Sell

Neutral

Buy

Collplant Biotechnologies is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Collplant Biotechnologies (CLGN) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Collplant Biotechnologies Ltd logo
-21.26%
-38.27%
-53.46%
-74.5%
-78.28%
Regeneron Pharmaceuticals, Inc. logo
-17.1%
-41.85%
-37.2%
-21.74%
-0.85%
Beone Medicines Ltd logo
-13.12%
5.03%
78.34%
40.23%
43.44%
Vertex Pharmaceuticals Incorporated logo
-4.76%
2.3%
24.05%
71.43%
78.99%
Alnylam Pharmaceuticals, Inc. logo
-9.09%
-19.67%
62.43%
39.66%
61.91%

About Collplant Biotechnologies

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; as well as develops injectable breast implants and 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures. It has collaboration agreements with Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; International Society for Biofabrication; AbbVie; and STEMCELL Technologies. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. The company was incorporated in 1981 and is headquartered in Rehovot, Israel.
Organization
Collplant Biotechnologies
Employees
57
CEO
Mr. Eran Rotem CPA
Industry
Health Technology

Management People of Collplant Biotechnologies

NameTitle
Mr. Yehiel Tal
CEO & Director
Mr. Eran Rotem CPA
Deputy CEO & CFO
Mr. Oren Fahimipoor
Vice President of Operations
Dr. Elana Gazal
Vice President of Research & Development
Prof. Oded Shoseyov
Founder & Chief Scientist
Ms. Hadas Dreiher Horowitz
Vice President of Human Resources

Important FAQs about investing in CLGN Stock from India :

What is Collplant Biotechnologies share price today?

Collplant Biotechnologies share price today stands at $2.42, Open: $2.46 ; Previous Close: $2.42 ; High: $2.46 ; Low: $2.42 ; 52 Week High: $6.75 ; 52 Week Low: $2.20.

The stock opens at $2.46, after a previous close of $2.42. The stock reached a daily high of $2.46 and a low of $2.42, with a 52-week high of $6.75 and a 52-week low of $2.20.

Can Indians buy Collplant Biotechnologies shares?

Yes, Indians can invest in the Collplant Biotechnologies (CLGN) from India.

With INDmoney, you can buy Collplant Biotechnologies at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Collplant Biotechnologies at zero transaction cost.

How can I buy Collplant Biotechnologies shares from India?

It is very easy to buy Collplant Biotechnologies from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Collplant Biotechnologies (CLGN) be purchased?

Yes, you can buy fractional shares of Collplant Biotechnologies with INDmoney app.

What are the documents required to start investing in Collplant Biotechnologies stocks?

To start investing in Collplant Biotechnologies, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Collplant Biotechnologies Stock (CLGN)?

Today’s highest price of Collplant Biotechnologies (CLGN) is $2.46.

Today’s lowest price of Collplant Biotechnologies (CLGN) is $2.42.

What is today's market capitalisation of Collplant Biotechnologies?

Today's market capitalisation of Collplant Biotechnologies CLGN is 27.7M

What is the 52 Week High and Low Range of Collplant Biotechnologies Stock (CLGN)?

  • 52 Week High

    $6.75

  • 52 Week Low

    $2.20

What are the historical returns of Collplant Biotechnologies (CLGN)?

  • 1 Month Returns

    -21.26%

  • 3 Months Returns

    -38.27%

  • 1 Year Returns

    -53.46%

  • 5 Years Returns

    -78.28%

Who is the Chief Executive Officer (CEO) of Collplant Biotechnologies ?

Mr. Eran Rotem CPA is the current Chief Executive Officer (CEO) of Collplant Biotechnologies.